1. Research Background

The routine prevention and control of bacterial diseases has become a major focus in the livestock and poultry farming industry. In swine and poultry production systems, tetracycline-class antibiotics are widely used due to their broad-spectrum antibacterial properties (effective against Gram-positive bacteria, Gram-negative bacteria, and mycoplasma) and high clinical safety. As a result, they have become the first-choice antimicrobials in large-scale farms.

Representative formulations such as Oxytetracycline Hydrochloride Soluble Powder and Doxycycline Hydrochloride Soluble Powder function by specifically binding to the 30S subunit of bacterial ribosomes, thereby blocking the binding of aminoacyl-tRNA to the mRNA-ribosome complex, effectively inhibiting bacterial protein synthesis.

In practical use, waterline administration is the mainstream method due to its efficiency in mass medication. However, limited by the physicochemical properties of the drugs, there are technical bottlenecks such as poor solubility, low solution stability (easy crystallization and precipitation), and blockage of the medication delivery system. Therefore, the development of new formulation technologies to improve solubility and solution stability has become an important direction in veterinary drug formulation enhancement.

2. Application Bottlenecks: Poor Water Solubility, Instability, and Waterline Blockage

When used in waterline administration systems, tetracycline-class veterinary drugs such as Oxytetracycline and Doxycycline exhibit significant formulation challenges:

- Firstly, in aqueous solutions with pH ≥ 7, the drug molecules are prone to hydroxylation and degradation. They also form insoluble metal chelates with divalent metal ions such as Ca²⁺ and Mg²⁺, leading to precipitation that clogs the delivery system, hinders proper dosing, complicates cleaning, and increases operational costs.

- Secondly, conventional formulation techniques struggle to overcome phase separation phenomena caused by multi-component compound administration (e.g., vitamins, viscous polysaccharides, herbal oral solutions), which can lead to residue buildup on pipe walls, serving as a breeding ground for biofilms, delaying treatment, and increasing clinical risk.

3. Key Breakthrough: Overcoming Water Solubility Limitations

Through optimized formulation design, a compound system of chelating agents and surfactants was introduced to create a dynamic ion-buffering environment. The steric hindrance of molecular space was used to inhibit metal chelation reactions, making the formulation compatible with common waterline administration using tap water.

For example, formulations of Oxytetracycline Hydrochloride and Doxycycline Hydrochloride show the following solubility and stability characteristics:

Using a 50% Oxytetracycline Hydrochloride Soluble Powder as the model drug, a dissolution test was conducted at the maximum saturated concentration (400 g/L) in tap water. Real-time monitoring showed that the solution remained homogenous and stable over a 25-hour observation period, with no crystal transformation or drug precipitation observed (Figure A). This indicates that the formulation maintains physical stability for over 24 hours even at critical solubility levels.

Figure A: Stability Results of 50% Oxytetracycline HCl Soluble Powder Solution (400 g/L) Before and After 25-Hour

Stability of Drug Content in Solution:

A series of concentration gradients (1.0, 0.5, 0.25, and 0.2 g/L) were tested in tap water. High-Performance Liquid Chromatography (HPLC) was used to monitor the chemical stability of Oxytetracycline Hydrochloride over 24 hours. Results showed that the active ingredient retention rate in all concentration groups was 98.8% ± 0.4% (RSD < 2%), with no statistically significant difference compared to the initial concentrations (p > 0.05). These results confirm that the drug solution can maintain chemical stability for at least 24 hours under conditions simulating waterline retention in farms, meeting the clinical effective concentration standards outlined in the Guidelines for the Stability of Veterinary Chemical Preparations.

Figure B: Stability Results of Diluted 50% Oxytetracycline HCl Soluble Powder Solutions at Various Concentrations Before and After 24 Hours.

4.Clinical Applications

- Oxytetracycline Hydrochloride:

  Indications: Used to treat infections caused by susceptible strains of Escherichia coli, Salmonella spp., Pasteurella spp., and Mycoplasma in pigs and poultry.

 - Doxycycline Hydrochloride:

  Indications: Used to treat infections caused by Gram-positive and Gram-negative bacteria including E. coli, Salmonella, Pasteurella, and respiratory diseases caused by Mycoplasma in pigs and poultry.

5. Conclusion

Through formulation optimization and innovation, the solubility of the drug has been significantly enhanced (more than 300 times the standard dosage), and the stability of the drug in aqueous solution has been extended (≥24 hours). This provides a reliable technical solution for intensive livestock farming.